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Abstract
ASSESSMENT OF LV SYSTOLIC FUNCTION BY VELOCITY VECTOR 
IMAGING
BACKGROUND: Assessment of LV systolic function is an important parameter in evaluation 
of cardiac disease. Echocardiography is the most widely used non invasive imaging modality 
in the assessment of LV function. Current methods of assessing LV systolic function have 
limitations. Velocity vector imaging (VVI) is a new modality that uses 2D (B-mode) images to 
determine tissue motion and velocity by application of a tracking algorithm.  In this study, we 
assessed the utility of VVI in the measurement of LV systolic function in comparison to 
radionuclide imaging and standard 2D echo.
METHODS: We measured global and regional LV systolic function by ejection fraction (EF) in 
49 patients using VVI, standard 2D echo and nuclear imaging (SPECT).  Patients were 
categorized as normal; mild, moderate or severe LV systolic dysfunction based on American 
Society of Echocardiography classification. The results were analyzed by appropriate 
statistical tests for correlations. 
RESULTS:  The mean EF for the study population as measured by VVI was 35 ± 12.08%, as 
compared to 54.2 ± 19.51%  with SPECT (p<0.001 vs VVI) and 50.3 ± 8.92% with 2D 
echo(p<0.001 vs VVI). There was a positive linear correlation between EF measured by VVI 
and the other modalities (Pearsons correlation coefficient 0.577 for SPECT and 0.573 for 2D; 
p = 0.01).  However, VVI systematically underestimated the EF in comparison to SPECT. 
There were significantly greater proportion of patients classified as having moderate or severe 
LV systolic dysfunction by VVI (75.5%) when compared to SPECT (34.7%; p=0.026).  We 
derived a correction factor to calculate SPECT EF from VVI EF: EF (SPECT) = EF (VVI) x0.9 
+ 21 or approximately VVI (EF) +20. There was good inter-observer correlation for EF 
measured by SPECT.
CONCLUSION: VVI was found to underestimate the ejection fraction as compared to that 
measured by gated SPECT. A correction factor can be incorporated into the VVI algorithm to 
improve its accuracy.
INTRODUCTION
Cardiovascular disease is one of the leading causes of morbidity and mortality worldwide. Our 
country has faced an epidemic of ischemic heart disease over the past decade. Hence new 
tools for diagnosis and prognostication in heart disease are constantly being developed and 
evaluated.
Measurement of left ventricular (LV) function has a central role in the assessment of a wide 
variety of cardiac diseases. While measurement of systolic function is almost always done as 
a routine, detailed evaluation of diastolic function is done in selected instances. The degree of 
LV systolic dysfunction is a powerful predictor of cardiovascular morbidity and mortality1 and 
is often crucial in deciding therapy. Clinical evaluation alone has been shown to have poor 
sensitivity and specificity to detect LV dysfunction, while the electrocardiogram and chest X-
ray have only limited utility2. Though several new tools such as CT and MRI have entered the 
diagnostic armamentarium, echocardiography continues to be the most important and widely 
used modality in the measurement of LV systolic function. In this regard, the ejection fraction 
(EF) has been the most commonly used measure of LV systolic function. With real-time two 
dimensional imaging of the heart, it has been possible to rapidly and non-invasively measure 
EF and also perform serial measurements to track the course of disease. EF is a simple and 
easy to understand numeric measure, and has been shown to predict survival3. Though EF 
has limitations as a true indicator of LV function, it continues to have global appeal4. However, 
a greater problem often is technical difficulties in measurement of EF, especially with respect 
to correct endocardial border detection which is crucial to the accuracy of measured EF5. In 
the era of revolutionary device therapy for heart failure, accurate measurement of EF has 
assumed even greater importance than before, as it is a crucial deciding factor in cardiac 
resynchronization (CRT) and implantable cardioverter defibrillator (ICD) therapy6. Thus it is 
important to look at ways and means of overcoming technical limitations in measurement of 
EF by echocardiography.
Speckle tracking echocardiography (STE) is an exciting new tool with promising potential 
which uses natural acoustic markers in conventional gray scale ultrasound images7. This can 
be potentially used to track motion of the myocardium. A new technology based on speckle 
tracking is velocity vector imaging (VVI) which displays velocities of the myocardium using a 
unique and multi-dimensional tracking algorithm8. VVI may thus be helpful in accurately 
tracking endocardial movement and potentially improving measurement of LV volumes and 
EF. There are no studies systematically assessing the utility of VVI in the assessment of LV 
systolic function. The present study was hence undertaken to measure ejection fraction with 
VVI and to compare it with standard two dimensional (2D) echocardiography and nuclear 
single photon emission computed tomography (SPECT).
AIMS AND OBJECTIVES
Aim:
The aim of the study is to assess the accuracy of the new echocardiographic modality, 
velocity vector imaging in measuring left ventricular ejection fraction by comparing it with 
nuclear gated SPECT and standard 2D echo.
Objectives:
1. To measure global and regional EF using velocity vector imaging in a cohort of patients.
2. To find out the correlation between EF measured by VVI and that measured by nuclear 
gated SPECT and standard 2D echo.
3. To classify patients into categories of LV dysfunction based on EF measured by VVI and 
compare it with similar categorization done using SPECT and 2D echo.  
4. To calculate a correction factor, if needed, for EF measurement by VVI, keeping 
SPECT as the “gold standard”
 REVIEW OF LITERATURE
Echocardiography is an extremely useful and extensively used investigative modality. Its 
advantages include ease of performance, ready availability, portability and avoidance of 
intravenous contrast or radiation. The assessment of LV systolic function is a key part of the 
echocardiographic examination. Various methods are available to measure LV systolic 
function by echo, though none is perfect. It is being increasingly recognized that left 
ventricular geometry9 and motion is complex and multi-dimensional, and a single measure of 
LV systolic function may not be all-encompassing. Thus, there is a constant endeavour to 
develop newer echocardiographic techniques to better assess LV performance.
Physiology of Cardiac contraction:
The myocardial muscle cells or myocytes are the cells responsible for executing the 
contraction-relaxation function of the heart. They constitute a major volume and mass of the 
myocardium. Groups of myocytes form myofibers. Myocytes are bound by a membrane called 
the sarcolemma which forms invaginations called T tubules. The major cellular organelle 
within the myocyte responsible for triggering contraction is the sarcoplasmic reticulum (SR) 
which has large stores of calcium. A wave of depolarization initially releases a small amount 
of calcium from the T tubules which then cause a larger release from the SR initiating 
contraction. Conversely, when the calcium is taken back into the SR, relaxation ensues. 
The contractile proteins of the heart are the thin actin and thick myosin filaments. Calcium 
ions start the contraction process by interacting with troponin C and remove the inhibitory 
effect of troponin I. Contraction is achieved by sliding of the actin over the myosin filaments. 
By this, the two ends of the fundamental contracting unit, called the sarcomere are drawn 
towards each other, resulting in shortening.  Contraction is an energy-dependent process 
which is achieved by breakdown of adenosine triphosphate (ATP).  The opposite process 
occurs in relaxation. An understanding of the molecular mechanisms involved in contraction-
relaxation helps to clarify the role of physiologic and metabolic factors in modulating LV 
contraction. For example, catecholamines increase LV contractility by acting on β1 adrenergic 
receptors which cause a cyclic AMP mediated increase of calcium release from the 
sarcoplasmic reticulum.
The Cardiac Cycle:
Onset of left ventricular contraction caused by depolarization causes a build up of pressure in 
the LV.  When left ventricular (LV) pressure exceeds left atrial pressure, closure of the mitral 
valve occurs producing the first heart sound. This is followed by isovolumic contraction, during 
which time pressure in the ventricle rapidly rises. When the LV pressure exceeds aortic 
pressure, the aortic valve opens and the phase of ejection begins, during which time, the LV 
volume declines. In the first half of ejection, LV pressure exceeds that of the aorta producing 
rapid ejection, while in the second half as LV pressure declines, slow ejection is maintained 
by the elastic recoil of the aorta. The aortic valve closes at the end of ejection producing the 
second heart sound and diastole starts.  As the LV pressure drops below that in the left 
atrium, the phase of early or rapid filling occurs. Active diastolic relaxation in early diastole 
creates a suction which aids in rapid filling. As the pressures in the atrium and LV equalize, 
filling almost stops (diastasis) and then occurs again in late diastole by virtue of the atrial 
contraction. Normally most filling occurs during the early filling phase. However, atrial 
contribution becomes important when cardiac output needs to rise as during exercise, or 
when ventricular relaxation is impaired due to stiffening of the ventricle as in pathological 
hypertrophy10. LV volume is maximal at end diastole and minimal at end systole.
Frank-Starling Mechanism: 
Within physiological limits, if a larger heart volume increases the initial length of the muscle 
fiber, the contraction is stronger and thus more blood would be ejected. The rate of rise of 
pressure is more rapid and so is the rate of relaxation11. This principle is important in changes 
in cardiac output which occurs in physiological conditions.
Preload refers to the initial ventricular volume or pressure prior to onset of contraction, which 
would essentially be the state of the ventricle at end-diastole. As evident from the Frank-
Starling principle described above, preload is important in determining the strength of the 
subsequent LV contraction.
Afterload refers to the systolic load on the ventricle once it has started to contract and 
essentially offers resistance to ventricular ejection. The degree of afterload dictates LV wall 
stress.  In a normal heart, the LV can overcome most acute changes in load. However, if a 
significant resistance continues over a period of time, compensatory change in the form of 
hypertrophy would occur to generate additional pressures.
Definitions:
Systole is defined as the portion of the cardiac cycle from mitral valve closure to aortic valve 
closure. 
Stroke volume is the amount of blood ejected from the left ventricle in a single cardiac cycle 
and the total amount of blood ejected in a minute is the cardiac output. Thus the cardiac 
output equals the product of the stroke volume and the heart rate.
LV systolic function is a measure of the contractility of the left ventricle. This is affected by 
several factors including heart rate, metabolic factors and drugs. Additionally the preload and 
the afterload (aortic resistance/impedance) also determine the stroke volume. Increasing 
preload causes an increase in stroke volume by the Frank-Starling mechanism11, while an 
increase in afterload results in a fall in the stroke volume. Thus, a pure measurement of 
ventricular contractility independent of loading conditions poses challenges.
Diastolic function refers to the relaxation properties of the LV. Normal diastolic function is also 
important to the overall function of the heart, as a proper and adequate relaxation determines 
the preload of the subsequent systole. Hence systolic and diastolic functions are not strictly 
separate and are in fact intertwined with each other. However, for clinical purposes, they are 
studied separately using different measures.
Various methods have been developed in echocardiography to measure LV systolic function 
including M-mode, 2D, Doppler and new techniques such as tissue Doppler imaging, strain 
and strain rate. In addition, 3D echo has now emerged as a potential tool for accurate LV 
volume measurement. A brief overview of these methods is given below before discussing the 
emerging avenues of speckle tracking and velocity vector imaging.
M-MODE:
The early attempts to measure LV function used M-mode echocardiogram to perform linear 
measurements of the LV. The advantage of M-mode is the superior temporal resolution 
compared to 2D echo. Measurement of the LV dimensions in end diastole and end systole 
give an idea of the LV volumes. 
Fractional shortening (FS) can be calculated as the difference between the end diastolic and 
end systolic dimensions of the LV, divided by the end diastolic dimension. Fractional 
shortening is a rough measurement of LV systolic function; with the measured value being 
compared to an established normal range 12. Although simple to measure, FS is dependent 
on loading conditions and heart rate13.  
The velocity of circumferential fiber shortening (Vcf) is obtained by dividing FS by the ejection 
time and is relatively preload independent14.  
Another linear measurement is the descent of the base. During LV contraction, the base of 
the heart moves toward the apex, and as the apex is relatively fixed; this movement is directly 
proportional to systolic function. M-mode interrogation of the lateral mitral annulus is done and 
the amount of excursion determined.
E-point septal separation: The magnitude of opening of the mitral valve, which is seen as the 
height of the E-wave in an M-mode cut, correlates with transmitral flow and therefore stroke 
volume. Similarly, the LV internal dimension in diastole correlates with end-diastolic volume. 
So, a comparison of the above two parameters can give an idea of the ejection fraction. This 
is obtained by measuring the distance between the mitral valve E point and the left side of the 
ventricular septum. An increase in this distance reflects a decreased ejection fraction. 
Looking at the pattern of aortic valve opening also provides indirect assessment of LV 
function. If the stroke volume is reduced, there is a gradual reduction of forward flow in late 
systole, which results in a gradual closure of the aortic valve giving a rounded appearance15. 
Regional function can be assessed by looking at systolic thickening. However, this requires 
both the endocardium and the epicardium to be defined; the latter posing technical difficulties. 
2D guided M-mode imaging in different planes may have to be used for optimal visualization; 
however normal ranges for quantitative assessment have not been well defined.
M-mode suffers from certain disadvantages. It can underestimate or overestimate the LV 
function if the M-mode beam is oblique with respect to the long or short axis of the ventricle. 
Even using 2D guided M-mode; it may not be always possible to align the beam properly. 
Further, M-mode provides assessment along a single line of interrogation and regional 
variation in ventricular function is not accounted for. Methods have been developed to 
calculate volumes and ejection fraction from M-mode measurements such as the Teichholz 
method and the Quinones method but these suffer from the shortcoming of making inaccurate 
assumptions about LV cavity shape and size16. Increasingly, M-mode is being supplanted by 
more direct measures of LV size and function available from two dimensional 
echocardiography.
TWO DIMENSIONAL ECHOCARDIOGRAPHY:
Two-dimensional echocardiography (2 D echo) gives greater spatial resolution to measure LV 
function. Determination of LV volumes is based on endocardial border tracing at end-diastole 
and end-systole in one or more planes. Prerequisites for a good 2D examination include good 
image quality, adequate endocardial definition and proper visualization of the apex of the LV.
A simple 2D measure of LV function is the fractional area change (FAC) which is calculated in 
the short axis view of the left ventricle by comparing the diastolic area with the systolic area. 
However, this represents LV function only at the level being interrogated and thus will not 
reflect regional dysfunction. 
Ejection Fraction:
2D echo is used to measure left ventricular volumes and to calculate the ejection fraction (EF) 
from it. The difference between the end-diastolic and end-systolic volumes of the LV gives the 
stroke volume. Ejection fraction is defined as the stroke volume divided by the end-diastolic 
volume and expressed as a percentage.
Methods of assessment of EF by 2D echo:
Subjective Assessment: Since EF is a unitless ratio, it is often assessed by visual estimation, 
which in the hands of experienced echocardiographers has been found to have reasonable 
correlation with trackball measurements17. However, this does not measure actual LV 
volumes which are also important and is subject to error especially if there is irregular rhythm 
or significant tachycardia.
LV Volume Measurement: Due to the complex shape of the LV, geometric assumptions have 
to be made in extrapolating volumes from 2D images. Various geometrical formulas have 
been used such as the area-length method, single-plane ellipsoid, biplane-ellipsoid and 
hemisphere cylinder18, all of which have shortcomings and are based on the assumption that 
the ventricle will adhere to a predictable shape. Regional dysfunction further decreases the 
accuracy of these methods.
Simpson’s Rule: With improvement of resolution in 2D echo, direct assessment of LV 
volumes in apical views has become possible and the most commonly used method now for 
estimating EF is the Simpson’s rule. The endocardial border is defined in an apical 2 or 4 
chamber view in end-diastole and end-systole. The ventricle is divided into a series of disks 
along the long axis from apex to base and the LV volume is obtained by summation of the 
volumes of individual disks19. This method is not completely free from geometric assumption 
as each disk is expected to be circular. Foreshortening of the LV apex will result in incorrect 
measurement of EF. Other potential pitfalls include failure to direct the ultrasound beam 
through the center of the LV resulting in a tangential cut and inaccurate tracing of the 
endocardial borders due to myocardial dropout or poor image quality which results in 
erroneous volumes. Tissue harmonic imaging20 and contrast echocardiography21 help to 
overcome the latter problem to some extent.  Intravascular contrast agents significantly 
improve endocardial border detection and EF measured using contrast echo has been shown 
to correlate with 3D echo and MRI22.  Also, techniques for automated identification and 
tracking of the endocardial border and automatic quantification of LV volume, such as 
acoustic quantification23 and colour kinesis24 have been developed but these require 
calibration and have not come into routine use.
Figure1. Simpsons method: Systolic and diastolic frames
Advantages of EF:
Ejection fraction is widely used as it is easy to obtain and has been shown to robustly predict 
mortality,3 i.e. lower the EF, lower the survival.  EF has been shown to be more important 
than the number of diseased coronary arteries25 or the degree of perfusion defects26. EF has 
not only prognostic implications, but also guides therapeutic decision making. Many large 
multicenter trials have used EF as the sole measure of LV function. It has become the 
gatekeeper for biventricular pacing, defibrillator implantation6 and drug therapy initiation. 
Thus, a lot of weightage is given to this particular parameter.
Disadvantages:
Technical difficulties in measurement, especially endocardial border definition have already 
been mentioned. Interobserver variability exists in measured EF. In addition, EF is dependent 
on both preload and afterload. In aortic stenosis, the increase in afterload due to outflow 
obstruction falsely attenuates the EF, which improves after the obstruction is removed. In 
mitral regurgitation, the low afterload due to decompression of the LV into the dilated left 
atrium (LA) falsely augments EF27.  After the mitral valve is repaired or replaced, the EF could 
deteriorate as the route into the low pressure LA sink is closed. Thus for the same degree of 
ventricular contractility, EF can differ depending on the loading conditions. This makes serial 
follow up studies difficult as loading conditions may not be the same and actual ventricular 
volumes may be more useful to track remodelling28.  In a situation of acute ischemia such as 
during an acute coronary syndrome, non ischemic segments may become hyperkinetic and 
compensate for the poorly contracting ischemic area, with overall EF remaining in the normal 
range. As the function of the ischemic segment recovers, hyperkinesis would resolve and 
those segments would revert back to their normal state of contraction. All this while, EF has 
not changed, even though considerable pathophysiological processes have occurred.
Increasingly, use of EF alone has been considered insufficient as a comprehensive measure 
of LV systolic function especially in view of availability of new echocardiographic methods and 
better understanding of the dynamics of LV function in recent times29.
Load corrected parameters:
As mentioned above, loading conditions affect measurement of the LV function and there 
have been attempts to derive parameters which correct for the loading state. LV midwall 
shortening expresses the stress shortening relation of the ventricle. The use of midwall 
shortening is less dependent on LV geometry than are endocardial measurements. The other 
approach is to draw pressure-volume loops to show the association between loading and 
inotropic state. The end systolic pressure volume relationship is drawn or LV wall stress 
against LV dimension can be plotted. An increase in the slope of the curve corresponds to 
increased contractility and decrease corresponds to reduction in contractility. These 
parameters are not easy to measure non-invasively and are not used in routine practice18.
Three Dimensional Echocardiography:
The development of three dimensional echocardiography (3D echo) has marked a major step 
forward in accurate assessment of ventricular volumes and function, given that 2D echo has 
shortcomings in capturing the complex geometry of the LV. In 3D echo, cardiac structures are 
shown in relationship to each other in all three spatial dimensions. 
Earlier approaches to 3D echo used a series of 2D images to reconstruct a 3D data set using 
offline software. The quality of 3D reconstructions from 2D images depends on a number of 
factors, including the intrinsic quality of the ultrasound images, the number (or density) of the 
2D images used to reconstruct the 3D image, the ability to limit motion artifact, and adequate 
ECG and respiratory gating. In general, the greater the number of images obtained (i.e., the 
smaller the space intervals between images), the better the 3D reconstruction. However, 
increasing the number of images also lengthens the acquisition time, which can potentially 
introduce motion artifact. Consequently, the optimal number of images necessary for 3D 
reconstruction depends on the cardiac structure being examined and the resolution required. 
For example, 4 to 6 serial images are usually adequate for volume reconstructions of the left 
ventricle (LV), whereas more images are often needed to visualize more complex, rapidly 
moving structures, such as mitral and aortic valves.
The development of Real Time 3D (RT3D) echocardiographic systems circumvents many of 
the disadvantages of reconstructive methods. RT3D echocardiography uses a transducer with 
ultrasound elements arranged in a grid fashion. Modern 3D transducers have matrix-array 
transducer technology with more than 3000 imaging elements which obtain a pyramidal 
volume data set and give images of good quality. Some form of gating needs to be used in 
obtaining volumetric data. There are three acquisition modes in RT3D- namely, real time 
(narrow), zoom (magnified), and wide angle. The real-time mode displays a pyramidal data 
set of approximately 50° × 30°. The zoom mode displays a smaller, magnified pyramidal data 
set of 30° × 30° at a higher resolution. The wide-angle mode provides a pyramidal data set of 
approximately 90° × 90°, which allows inclusion of a larger cardiac volume30.
Figure 2. Progression from 2D imaging to 3D narrow-angle (NA) to 3D full-volume (FV) imaging.
Measurement of LV Volumes & function:
The wide-angle acquisition mode can be used to acquire the entire LV volume, from which a 
detailed analysis of global and regional wall motion can be done. Images may be displayed 
with either orthogonal long-axis views or multiple short-axis views. Intravenous contrast can 
be used as in 2D to better define the endocardial border. Multiple studies have validated the 
volumes measured by 3D against MRI and other modalities31, 32. It has been shown to be 
superior to 2D echo in measurement of ventricular volumes especially in abnormally shaped 
ventricles; however the challenge has been to improve the level of accuracy to the extent that 
it impacts clinical decision-making over and above the information provided by 2D. 
Right Ventricle: As the right ventricle has an asymmetrical pyramidal shape, assessment by 
2D echo has limitations as it does not conform to geometric assumptions. Three dimensional 
imaging of the entire RV, especially with real time 3 D echo holds potential to more accurately 
assess RV function. Studies done using 3D echo involving offline processing of 2D data have 
demonstrated improved accuracy in assessing the RV33.
The main limitation of 3D echo has been the difficult process of reconstruction using data 
from multiple 2D image sets, where even minor changes in transducer position will 
significantly affect image quality and endocardial definition. The availability now of faster 
processors and improved computer algorithms which allow real time 3D data acquisition has 
been more accurate. 3D echo is likely to be the future technology of choice to assess 
ventricular volumes and remodelling but the technology is not readily available at present.
Regional Function Assessment by 2D echo:
Subjective Assessment: 
As echocardiography is frequently used to assess coronary artery disease, where perfusion is 
deficient to certain areas of the myocardium, assessment of regional function is particularly 
important. Subjective assessment can be done by describing regional wall motion abnormality 
(RWMA) i.e. the contractility of specific segments as normal, hypokinetic, akinetic or 
dyskinetic. The American Society of Echocardiography has proposed a standard 16 segment 
model for description of RWMA. Recently a 17th segment, namely the true apical segment has 
been proposed. The area affected gives an idea of the probable culprit coronary artery (fig 3). 
A semiquantitative method is the wall motion score index (WMSI) in which motion is scored 
as 1 for normal, 2, 3 and 4 for hyokinesia, akinesia and dyskinesia respectively. The total 
score thus obtained is divided by the number of segments analyzed to obtain the WMSI. This 
acts as an index of global LV function and has been shown to correlate with prognosis34.
Quantitative methods:
 In order to introduce an element of objectivity, certain quantitative methods to assess 
regional function have been proposed.
Figure.3 The 16 segment American Society of Echocardiography model for characterization of regional LV 
function, and usual coronary artery distribution of the segments.
 1. Center line method- In this, the end diastolic and end systolic endocardial borders are 
traced and superimposed on each other. A center line is interpolated and the distance from 
this center line of different points in the endocardium in systole and diastole can be measured 
by a series of chords extending perpendicular to the center line. This gives an idea of the 
displacement from
diastole to systole. This has also been called chordal shortening method. This method has 
shortcomings and is also time consuming.
2. Colour Kinesis method- This method uses acoustic quantification to define the border 
based on the difference in backscatter between the LV cavity and the endocardium. The 
excursion of the myocardium is tracked in successive frames and each is given a different 
colour code. The resultant display is overlaid on the 2D image and displacement calculated 
as segmental area shrinkage, is portrayed as stacked histograms. This method requires good 
image quality. Rotational and translational (movement of the heart within the chest cavity) 
movement of the heart contributes to errors18.
 RWMA can be present without ischemia in conditions such as bundle branch block, pacing, 
pre-excitation and post cardiac surgery. However, in these conditions, systolic thickening is 
preserved, which is almost invariably affected in true regional dysfunction.
DOPPLER EVALUATION OF LV FUNCTION: 
Doppler measurement of flow can be used to assess LV function. The simplest technique is to 
calculate stroke volume by measuring the time velocity integral (TVI) of the LV outflow tract 
(LVOT), which is then multiplied by the cross sectional area of the LVOT to obtain volume. 
Comparison of left and right sided ejections by this method can be used to calculate their ratio 
(Qp/Qs) in congenital heart disease.  Though it is simple, small errors in measuring the 
dimension of the LVOT would result in large variations in the final volume measured. 
Another useful method is the rate of rise of pressure (dp/dt) in the LV. The longer it takes to 
develop pressure, the worse the contractility (slower slope correlates with worse function). 
Peak LV positive dp/dt occurs typically in early systole before the aortic valve opens, thus 
limiting the influence of afterload. Mitral regurgitation needs to be present in order for dp/dt to 
be measured by echo. It is determined by measuring the time it takes for the mitral 
regurgitation jet velocity to increase from 1 m/sec to 3 m/sec which represents the time taken 
for a pressure change of 32 mm Hg to occur. The dp/dt is then calculated as 32 divided by the 
measured time. The negative dp/dt measured over the second half of the curve is an indicator 
of diastolic function and relaxing properties of the ventricle. Dp/dt overcomes the problem 
associated with using EF in a patient with significant MR which was described earlier. It has 
been found to be an independent prognostic indicator in heart failure35 and can help predict 
the occurrence of LV dysfunction after mitral valve replacement36. 
The myocardial performance index (MPI or Tei index) is a relatively load-independent 
measure of LV function37. It is calculated as the sum of the isovolumic contraction time (ICT) 
and isovolumic relaxation time (IRT), divided by the ejection time (ET). It is measured using 
the Doppler inflow of the mitral valve and that of the LVOT as shown in figure 4. This is said to 
be a measure of both systolic and diastolic function38 and is useful in assessing right 
ventricular performance also39.
Using the Doppler profile of mitral valve inflow, parameters of diastolic function can also be 
calculated such as the early filling (E) and atrial (A) wave velocities and the deceleration time 
of the LV. The pulmonary and hepatic vein flow profiles are also useful in measuring diastolic 
function.
Figure 4. Tei Index measurement
Measurement of wall stress:
Wall stress is defined as the force over each unit of cross sectional area and the force is 
determined by pressure in the ventricular cavity. As it accounts for both wall thickness and 
pressure generation, it is relatively afterload-independent and has been used for 
measurement of myocardial contractility. It can be calculated globally or regionally, as well as 
in mutually orthogonal planes i.e. meridional stress imposed by long axis (base-apex) 
shortening and circumferential stress in the minor axis40, 41. Measures of wall stress are most 
useful in ventricular pressure or volume overload states such as hypertension, aortic stenosis 
and mitral or aortic regurgitation.
TISSUE DOPPLER IMAGING:
Tissue Doppler imaging (TDI) is an exciting new tool that is easy to perform and 
reproducible42. This technique uses specific receiver gains and frequency filters to eliminate 
blood motion and track the actual motion of the myocardial wall. Myocardial tissue velocity is 
typically an order of magnitude below that of blood velocity. The signal from tissue movement 
is displayed as a colour display overlaid on the anatomical image itself, or more commonly 
pulsed Doppler is used for spectral analysis of TDI velocities which is more reliable. TDI has 
good spatial and temporal resolution. A number of parameters can be derived from TDI in 
systole and diastole which have been proposed to be useful in a variety of cardiac diseases43.
Magnitude of excursion of the mitral annulus has been shown to be a sensitive measure of LV 
function; is affected early by ischemia44 and correlates with LVEF45. Measuring this using M-
mode is tedious. Peak systolic velocity in ejection period measured using TDI at the mitral 
annulus (Sa) or at myocardial segments (Sm) is easier to perform. Peak myocardial systolic 
velocity averaged from 6 sites around the mitral annulus correlates well with LVEF, and a cut-
off of >7.5 cm/s had a sensitivity of 79% and a specificity of 88% in predicting normal global 
LV function46.  Reduced TDI velocities have been shown to be useful in detecting mild 
impairment of LV systolic function in those with a normal EF or so called diastolic heart 
failure47 and  in diabetic subjects without overt heart disease48 . Reduced TDI velocities can 
be seen in subjects with hypertrophic cardiomyopathy mutations even at the time of 
subclinical disease when 
                   
                                         Figure 5. TDI of septal mitral annulus
hypertrophy is not present49. Hence TDI can be used for early identification of hypertrophic 
cardiomyopathy.
Peak early (Ea) and late (Aa) mitral annular diastolic velocities can also be measured as 
indices of diastolic function. Ea is a marker of the speed of myocardial relaxation50. Reduction 
in Ea is one of the earliest indicators of diastolic dysfunction and it remains reduced at all 
stages of diastolic dysfunction51, 52. Thus Ea remains low even when there is 
pseudonormalization or a restrictive filling pattern by conventional mitral inflow Doppler. 
Hence the E/Ea ratio increases as diastolic dysfunction worsens and has been shown to 
correlate with LV filling pressure or pulmonary capillary wedge pressure (PCWP) 53. E/Ea ratio 
greater than 15 is said to correlate with a PCWP of > 20 mm Hg. This ratio predicts survival 
after acute myocardial infarction54 and has incremental prognostic value over EF55. Reduced 
Ea has been shown to be associated with adverse outcome including mortality and 
hospitalization independent of clinical risk factors and Doppler derived indices such as 
deceleration time in patients with heart failure and also in those with hypertrophy and normal 
ejection fraction.
Reduced annular systolic and diastolic velocities are independent predictors of mortality, with 
Ea being a stronger predictor. Reduced velocities of < 3 cm/sec were found to be associated 
with a lower survival56. They also add incremental risk above wall motion scores in coronary 
artery disease and predict cardiac mortality. In patients with mitral regurgitation, reduced 
lateral mitral annulus systolic velocity could predict those who would develop reduction in EF 
after mitral valve replacement surgery. 
TDI has been used to measure peak myocardial displacement and velocity in those 
undergoing dobutamine stress echo. Reduced tissue velocity of < 6 cm/sec in stress echo 
has been shown to correlate with mortality and risk of acute coronary events even when 
assessment by wall motion score did not show a significant difference57. Another important 
application of TDI is in measuring mechanical dyssynchrony in heart failure subjects. The time 
to onset or peak of systolic velocity is assessed in different segments and the delay 
calculated58, 59. Dyssynchrony measured by TDI predicts clinical outcomes in heart failure 
even in subjects with narrow QRS60 on ECG and can help predict response after CRT61.
The main limitation of tissue Doppler is the angle dependency of the technique, as accuracy 
depends on good alignment of the pulsed Doppler in line with the region of interest. 
Assessment of apical function is therefore unsatisfactory. Also, use of tissue velocity 
examines tissue movement with respect to the transducer and not with respect to adjacent 
tissue. The movement of a given segment is influenced by the motion of the adjacent 
segments which is called the “tethering effect”. Thus, an ischemic poorly functioning segment 
could be “pulled along” because the adjacent segment is hyperkinetic. Strain and strain rate 
imaging help to overcome this limitation.
STRAIN AND STRAIN RATE:
Strain or myocardial deformation imaging is conceptually appealing as it does not rely on 
motion with respect to the transducer but the relative motion between two segments within the 
myocardium. Two tissue Doppler samples can be recorded within the LV wall; if the sample 
volumes are moving apart, tension is produced just as if a rubber band is being stretched 
(positive strain). If the points are moving towards each other, then it would be as if the rubber 
band is being collapsed and tension decreases (negative strain). Thus, positive strain 
corresponds to relaxation and negative strain corresponds to contraction. Raw Doppler 
information provides the rate of change of length of tissue (distance over time) or strain rate. 
A two dimensional assessment looking strictly at only length gives strain.
Strain & strain rate can be measured by TDI62 and more recently speckle tracking (described 
later). Strain Rate (SR) is a more sensitive measure than strain because a weaker contraction 
could theoretically reach the same peak strain, but at a slower rate. However, SR is noisier, 
limiting its ability to differentiate normal from abnormal. Determination of timing intervals and 
peak values in both longitudinal and radial views for both strain and SR can be obtained and 
compared with established normal values63, 64. Measurements of myocardial deformation with 
these techniques have been validated using microcrystals and magnetic resonance65, 66.
Strain and strain rate can be potentially used to identify viable myocardium67 and early 
ischemia68. Reduction of strain and SR has been correlated with myocardial fibrosis which 
itself is a marker of adverse cardiac risk69. It may also be useful as an indicator of subclinical 
disease70 and in assessing response to therapy71. Though implications of strain responses to 
therapy are not well established, it seems likely that an improvement in deformation is likely to 
have a beneficial outcome.
Disadvantages of strain & SR are the low signal to noise ratio and angle dependence. 
Significant data storage and computational ability is required for strain & SR studies. SR 
seems to be relatively independent of heart rate (chronotropy) 72 and relatively afterload-
independent70, but it would likely be preload-dependent, as initial diastolic dimension would be 
expected to affect strain by the Frank-starling principle. Improvement in techniques and 
further studies would likely delineate the full potential of strain rate imaging. 
SPECKLE TRACKING ECHOCARDIOGRAPHY:
Speckle tracking echocardiography (STE) has recently been introduced as a novel method for 
quantification of myocardial performance. It is angle-independent in contrast to TDI7. 
Speckles are natural acoustic markers that occur as small and bright elements in 
conventional grayscale ultrasound images73. They are produced as a result of constructive 
and destructive interference of ultrasound, back-scattered from structures smaller than a 
wavelength of ultrasound74. These speckles are distributed equally around in the myocardium 
on the ultrasound image and can be identified and followed in consecutive frames during the 
heart cycles. Software that has the ability to assess myocardial strain, strain rate, velocities 
and displacement from these speckles has recently been developed75. Different speckle 
tracking algorithms have been validated in experimental and human studies76, 77.
Figure 6. Myocardium from a 4 chamber view enlarged to show speckles
Longitudinal and radial strain can be estimated accurately by STE; in addition, myocardial 
velocities and displacement of the mitral annulus can be measured.  Circumferential strain 
can also be measured due to angle-independency of the method. STE has also been used to 
predict response to cardiac resynchronization therapy and a recent clinical study 
demonstrated that assessment of radial strain by STE may quantify dyssynchrony and predict 
immediate and long-term response to cardiac resynchronization therapy78. A limitation of STE 
is that the time resolution in studies using STE has been in the range of 60-100 frames per 
second to optimize speckle quality. However, higher frame rates may be needed to reliably 
measure myocardial strain and velocity.
STE technology is still evolving and few systematic studies are available, but so far it seems 
to provide an accurate, simple and direct measure of myocardial deformation and velocity. 
Thus it has the potential to become a bedside clinical tool. Another novel technology that 
further builds upon STE is velocity vector imaging (VVI) which is described below.
VELOCITY VECTOR IMAGING:
Velocity Vector Imaging (VVI) is a visual and quantitative method for assessing the dynamics 
of cardiac motion which uses the information within the image to determine tissue motion 
throughout the cardiac cycle.
Figure 7. Circumferential strain by STE. A, Circumferential strain from the apical LV level in a healthy individual. 
Note the homogenous circumferential distribution of normal systolic strain. B, Circumferential strain at the LV 
apical level in a patient with a LAD-related myocardial infarction. Note reduced systolic shortening (strain) in the 
anterior, septal, and inferior segments, with marked postsystolic contraction (white arrows). In addition, in the 
septal segments, there is early systolic stretching indicating dyskinesia (red arrow).
Technology:
VVI is not a simple speckle tracking algorithm alone, but also includes global motion 
coherence, consistency of periodicity between cardiac cycles and other techniques.  VVI 
extracts cardiac motion by tracking a user-defined trace which is typically drawn along an 
endocardial border. The trace is tracked throughout one or more cardiac cycles by successive 
applications of a series of tracking steps. By tracking key reference points, inward and 
outward border motion, motion of tissue along the direction of the border, and by constraining 
the tracking to be periodic over the R-R interval, VVI computes robust estimates of the 
cardiac motion. At each stage of the tracking, Fourier analysis is used and applies the 
constraint that the trace must return to the same location at the subsequent cardiac cycle79. 
Thus, the borders are not “detected”, but “tracked” over time. Prerequisites to use the VVI 
algorithm include a good quality 2D image encompassing the entire region of interest and at 
least one full R-R interval must be captured to enable the algorithm to use the periodicity of 
the cardiac cycle.
Image Display:
Yellow velocity vectors, placed on the B-mode image, indicate the direction and relative 
speed of the tissue, with longer arrows indicating proportionally higher velocities (fig 8). These 
velocity vectors are updated every frame to show velocities of the tissue region throughout 
the cardiac cycle. In addition, a graph of velocity vs. time is displayed showing the directional 
velocity relative to a user moveable reference point. For example, when the reference point is 
placed in the center of the left ventricular chamber, as in a short axis view, the radial velocity 
is seen. 
Figure 8. VVI analysis of a normal heart in diastole and systole
Strain and strain rate are calculated along the border. Strain is computed from the changing 
distance between the tracked trace points plus the differences in velocity of the tissue moving 
behind these points. Thus, strain reflects the relative change in distance between points of 
tissue along the border, reflecting lengthening or shortening.
VVI can also be used to assess cardiac dyssynchrony. VVI displays the tangential and radial 
velocity, strain, strain rate, and tangential and radial displacement for different myocardial 
segments. The time to peak value of these measurements can be obtained and displayed; 
thus lack of synchrony in motion of the different segments can be identified. This can also be 
easily visually appreciated by observing a trace overlaid with velocity vectors showing the 
speed and direction of movement of different regions (figure 9). 
It has been proposed that VVI would have additive value over TDI in analysis of dyssynchrony 
especially with regard to circumferential and radial mechanics of the ventricle and also be 
useful to assess resynchronization after CRT8. Cannesson et al. found that opposing wall 
peak velocity delay of ≥75 milliseconds predicted response after CRT with a sensitivity of 85% 
and specificity of 80%80.
By reliably tracking the endocardial border, VVI can compute ventricular volumes and ejection 
fraction using Simpsons rule. Regional function can be assessed by dividing each side of the 
trace into 3 segments of equal length and identifying regions with abnormal contractile 
function (figure 10).  Another potential application of VVI is in assessing rotational movement 
of the LV. Along with movements along the longitudinal and radial axis, during every 
contraction, the LV apex rotates in a counterclockwise direction, while the base rotates in a 
clockwise direction. The term LV torsion has been applied to this movement, which is 
technically difficult to measure using conventional echocardiography.
Figure 9. Radial velocity vectors in the apical short axis view from a normal (left panel) and a patient with LBBB 
(right panel). In the normal patient, in early/mid systole (A) and in late/end systole (B) the radial vectors are of 
similar magnitude and direction. In LBBB, in early/mid systole (C) the septal vectors are of higher magnitude 
than lateral radial velocities, in late systole (D) the septal vectors have peaked whereas the lateral wall vectors 
are directed in the opposite direction (dyssynchronous).
Figure 10. Global and regional EF by VVI
Using velocity vector display in short axis views at the apex and base, rotational movement 
can be visualized and quantified. Measurement of LV torsion is an area of active research 
using speckle tracking echocardiography81, 75 and VVI is likely to contribute to this in future. 
Other potential areas for use of VVI include assessment of right ventricular function82, left 
atrial mechanics, stress echocardiography and fetal echo79.
Other Methods to assess LV Function:
Though echocardiography is the most widely used, other modalities are available to measure 
LV function. A brief mention is made of these.
Cardiovascular magnetic resonance (CMR)  
This is a noninvasive 3-dimensional imaging technique which can provide morphologic and 
functional information as well as tissue characterization without the use of ionizing radiation or 
nephrotoxic contrast agents. It has a high accuracy and reproducibility and is optimally suited 
to quantify structural and functional abnormalities and to follow a patient over time. A specific 
advantage of CMR over echo is the ability to acquire images in any selected plane along the 
specific cardiac axes or any other, which makes it possible to thoroughly study cardiac 
morphology and function irrespective of patient build or habitus.  
Assessment of LV function: Bright blood gradient echo sequences, obtained during a 15- to 
20-second breath-hold, are used to cover the entire LV with short-axis views from the mitral 
plane and slice thickness not exceeding 10 mm.  Regional myocardial function is best 
assessed using a unique MR technique called myocardial tagging. Special modulation of 
magnetization is obtained by applying a radiofrequency pre-pulse that labels the heart muscle 
with a dark grid and enables three-dimensional analysis of cardiac rotation, strain (in the 
subendocardial, midwall, and subepicardial layers), displacement, and deformation of 
different myocardial layers during the cardiac cycle . The tags can be applied immediately 
after the R-wave on the electrocardiogram to image systolic function or in late systole to 
image diastolic function83. 
Viability: Contrast-enhanced MRI is rapidly evolving as a means of accurately predicting 
myocardial viability. On first-pass perfusion images, an area of hypoenhancement within the 
infarcted region, correlating with microvascular obstruction is observed. A second 
enhancement pattern is noticed at 10 to 30 min after contrast injection (delayed 
hyperenhancement [DHE]). The DHE can be used to detect changes after acute and chronic 
myocardial infarction. An association between transmural extent of DHE detected by 
magnetic resonance and functional recovery after revascularization has been shown. End 
diastolic wall thickness and systolic thickening can also be used as markers of viability84. This 
can be evaluated using dobutamine stress MRI.  
Further, imaging of the coronary arteries by MRI has been developed and though currently it 
is not ideal, it shows future promise in becoming a non-invasive modality to view the coronary 
tree85. 
Thus, CMR has been shown to have good accuracy in measuring LV volumes as well as in 
assessment of viability, but is constrained by availability of equipment and cost86.
Computed Tomography (CT): 
Conventional CT lacks the spatial or temporal resolution for adequate imaging of the heart; 
however recent use of multidetector array CT (MDCT) scanners and ECG gating has 
improved the imaging capability of CT. 
Wall motion abnormalities and areas of hypoperfusion can be assessed on the short-axis, 
four-chamber or two-chamber views, along with evaluation of the volumes and ejection 
fraction. This is done by performing a multi-phasic reconstruction at 5% intervals from the 
base to the apex of the heart, at 8mm intervals with 8mm thick slices. This yields 10 to 12 
"sections", each of which contains images at 5% intervals to allow smooth cine viewing. 
Overcoming cardiac motion artifacts is a significant problem and often heart rate needs to be 
lowered by the use of beta blockers to achieve adequate resolution in imaging87.  Studies 
have shown fair correlation between LV volumes and function obtained by MDCT and MRI88 
as well as conventional echo and nuclear gated SPECT89. Further, with the use of 64 slice 
CT, high resolution non invasive imaging of the coronary arteries has become possible and 
has already entered the clinical arena. It has been shown to have good sensitivity and 
specificity compared with conventional angiography for detection of significant coronary artery 
disease90.  Its real advantage lies in a consistently high negative predictive value observed in 
most studies, which allows one to exclude coronary artery disease with a high degree of 
confidence in the presence of a normal CT angiogram.
  However, at present there is not much data regarding the ability of CT derived LV function to 
predict risk in clinical practice18.  Also the imaging is hampered by the presence of high heart 
rate, arrhythmia and extensive calcification. Radiation exposure from MDCT has also been an 
issue of concern and the technique requires use of iodinated contrast. Nevertheless, 
combined assessment of coronary anatomy and LV function by MDCT is likely to become 
useful in the diagnostic armamentarium in evaluating coronary artery disease.
Nuclear Imaging: 
Nuclear imaging techniques to measure ventricular function include first pass 
ventriculography, equilibrium radionuclide ventriculogram (gated blood pool scanning), and 
gated single photon emission computed tomography (SPECT), during myocardial perfusion 
scanning with thallium-201 or Tc99m-sestamibi. These methods have been shown to have 
prognostic value after a myocardial infarction91 and add to risk stratification92
SPECT is a highly sensitive and moderately specific tool to detect coronary artery disease. 
Wall motion and systolic thickening can also be seen to assess regional myocardial status. LV 
volumes and EF measured by gated SPECT has been shown to correlate well with other 
techniques. EF can be calculated both at rest and post stress and the latter has incremental 
prognostic value over data provided by the perfusion study. Gated SPECT can detect wall 
motion and systolic thickening changes induced by inotropic stimulation; thus it can assess 
contractile reserve and myocardial viability. 
In recent times, gated SPECT is being used more and more to measure LV function alone in 
non coronary artery disease settings like dilated cardiomyopathy and has been used to 
predict response to therapy. Potential disadvantages with SPECT include presence of tissue 
attenuation artifacts and radiation exposure. Extensive perfusion defects could reduce the 
accuracy of LV volume and EF measurement.  This has been a rapidly growing field with new 
breakthroughs in technology and could possibly become a “one- stop-shop” for assessing 
coronary artery disease by combining CAD detection, LV function assessment and viability93.
Relevance of the present study
From the preceding discussion, it is clear that a variety of methods are available to measure 
LV systolic function. Left ventricular geometry is complex and contraction in systole involves 
movement in more than one axis. The arrangement of myocardial fibers is not uniform across 
the wall of the LV; subendocardial and subepicardial muscle bundles are aligned 
longitudinally, with a slight spiral arrangement, and midwall fibers are aligned 
circumferentially. The latter group of fibers are responsible mainly for short axis or radial 
contraction of the left ventricle, whereas the former cause long-axis contraction (figure 11)29. 
In addition, twisting and untwisting of the LV (torsion) also contributes to global LV function. 
Hence, assessment of this complex movement requires judicious application of different 
echocardiographic modalities and conventional 2D echo alone is no longer adequate in this 
regard. The development of tissue Doppler imaging, strain, strain rate and speckle tracking 
echocardiography represent important developments in understanding and measuring LV 
mechanics. 
Figure 11. Normal LV myocardium showing longitudinal fibers running between the apex and the mitral ring and 
occupying the subendocardial and subepicardial layers
As a simple to understand, easy to measure and powerful prognostic number, the ejection 
fraction is still one of the key measures of LV function in spite of its limitations. However, 
technical difficulties in measurement especially with regard to proper endocardial border 
definition can hamper accuracy. It is therefore important to evaluate new technologies which 
may have a potential role in this regard. VVI is an exciting new application of speckle tracking 
echocardiography that is able to measure velocity and direction of tissue motion using a 
complex tracking algorithm. VVI can efficiently track the endocardial border and has been 
said to have clinical utility in measuring LV volumes, EF and regional function.  However, 
there are no studies which have systematically evaluated the accuracy of EF measured by 
VVI.    
Hence this study was performed comparing ejection fraction measured by VVI to standard 2D 
echo and nuclear gated SPECT in a cohort of patients. This study is likely to give insights into 
the issues with the practical use of VVI in a clinical setting and the need for improvements if 
any.
METHODOLOGY
The study was performed among outpatients from the cardiology department of Christian 
Medical College, Vellore; a tertiary care institute in South India.  Subjects who presented to 
the outpatient area for evaluation of suspected coronary artery disease were prospectively 
recruited. 
Inclusion Criteria:
Patients presenting to the outpatient department of Cardiology for evaluation of chest pain 
were eligible to be included in the study.
Exclusion Criteria:
1. Inability to obtain a good quality echo image due to a poor window or other factors.
2. Unwillingness to participate in the study.
Baseline clinical data including risk factors, history of previous myocardial infarction, previous 
coronary angiography and current drug list was collected in all patients. Patients underwent a 
12 lead electrocardiogram and chest X-ray.
Echocardiography: 
Conventional 2D echocardiography in long axis, short axis and apical views were performed, 
and the ejection fraction calculated using Simpson’s rule. Patients were categorized as 
normal or having mild, moderate or severe LV dysfunction based on American Society of 
Echocardiography classification94. (Normal ≥55%, mild LV Dysfunction 45-54%, moderate LV 
Dysfunction 30-44%, severe LVDysfunction < 30%). Regional wall motion abnormalities were 
subjectively assessed and regions of reduced contractility described as hypokinetic, akinetic 
or dyskinetic.
VVI Analysis:
VVI analysis was performed using the Siemens Sequoia 512 machine (Siemens Medical 
Solutions USA, Inc.). After recording a 2D image of good quality, the LV endocardium was 
traced manually in the apical 4 chamber view to provide the basic trace which the VVI 
algorithm then used to automatically track endocardial border movement.  LV volume was 
calculated based on the volume of sixty-four disks whose diameters fit between opposing 
sides of the trace and are parallel to the plane defined by the trace endpoints (mitral plane). 
Regional volumes were computed by dividing each side of the trace into three segments of 
equal length and then dividing the disks into two portions using a line from the apex to the 
center of the base. This helps to identify regions with abnormal contractile function (refer Fig 
9. of literature review).
Nuclear Imaging:
Each patient also underwent nuclear perfusion study by gated SPECT using technetium 99m-
sestamibi from which presence and extent of regional ischemia was analyzed and ejection 
fraction was also calculated. In addition SPECT EF was calculated by another observer 
independently in 12 randomly selected patients to assess inter-observer variability.
Statistics:
Pearson’s correlation coefficient was used to analyze the correlation between ejection fraction 
calculated by VVI, SPECT and 2D echo. The numerical relationship between VVI EF and 
SPECT EF was calculated using regression equation to get an idea of the magnitude of 
difference in measurements by the two modalities. Paired t test was used to analyze 
continuous variables and chi square test or Fisher’s exact test to assess categorical variables. 
Significance was considered at a p value of ≤ 0.05. Statistical analysis was performed using 
SPSS version 10.
RESULTS
A total of 49 patients were studied.  Table 1 shows the demographic characteristics of the 
patients studied.
The mean age of the subjects was 55.04 ± 8.78 years; they were predominantly male 
(87.8%).  A little over 40% were diabetics and hypertensives and 40.8 % had suffered a 
previous ST elevation myocardial infarction (STEMI).  Twenty of the subjects had undergone 
a coronary angiogram out of which 2 (4.1%) were normal,  4 (8.2%) had minor coronary artery 
disease; 2 (4.1%), 6 (12.2%) and 5 (10.2%) subjects each had single, double and triple vessel 
coronary artery disease respectively. SPECT showed evidence of ischemia in about 27% of 
patients and fixed (irreversible) defects in about 30% of patients.
Measurement of Ejection Fraction:
The mean ejection fraction (EF) calculated by VVI was 35 ± 12.08%, as compared to 54.2 ± 
19.51% with SPECT and 50.3 ± 8.92% with 2D echo. The difference between the EF 
measured by different modalities was analyzed using the paired samples t-test. Table 2 
shows the paired samples statistics comparing VVI EF with SPECT and 2D echo. As seen 
from the table, the mean EF measured by VVI was significantly less than that measured by 
the other modalities (p<0.001).  
Table 1 Demographic Characteristics (numbers in brackets indicate percentages)
Age (mean+ SD) 55.04+ 8.78
Male 43 (87.8)
Diabetes 21 (42.9)
Hypertension 20 (40.8)
Smoker 15 (30.6)
Dyslipidemia 30 (61.2)
Angina 25 (51)
Dyspnea 22 (44.9)
NYHA Class I
Class II
Class III
13 (26.5)
33 (67.3)
3   (6.3)
Previous STEMI 20 (40.8)
Previous ACS (other than STEMI) 14 (28.6)
Q waves on ECG 15 (30.6)
RWMA by ECHO 17 (34.7)
Ischemia on SPECT 13 (26.5)
Aspirin 32 (65.3)
Beta blocker 28 (57.1)
Statin 35 (71.4)
ACEI/ARB 25 (51.1)
Nitrate 22 (44.9)
ACS = Acute coronary syndrome, ACEI = Angiotensin converting enzyme inhibitor, ARB = Angiotensin receptor 
blocker.
Table 2. Paired T-Test
Comparison 
Pair
Paired differences
Mean Std. 
Devn
.
Std. 
error 
mean
95% 
confidence 
inerval of the 
difference
Lower Upper t df
Sig. (2 
tailed)
SPECT EF-
VVI EF
19.22 15.96 2.28 14.64 23.81 8.432 48 <0.001
2D EF- VVI 
EF
16.26 10.05 1.53 13.16 19.35 10.612 42 <0.001
The Pearson’s correlation coefficient was used to look for a linear relationship between EF 
measured by VVI and the other modalities. Table 3 shows the statistics for Pearson’s 
correlation coefficient for SPECT and 2D EF in comparison to VVI.  There was a positive 
linear correlation between the VVI EF and SPECT EF (correlation coefficient 0.577; p=0.01) 
as well as 2D EF (correlation coefficient 0.573; p=0.01). Figure 1 shows a scatter plot that 
depicts this linear association between VVI and SPECT EF.
Table 3.  Pearson’s Correlation Coefficient Statistics
Modality Mean Standard 
Deviation
Pearson’s correlation 
with VVI EF
Significance (2 
tailed)
SPECT 54.22 19.51 0.577 0.01
2D 50.37 8.92 0.573 0.01
VVI 35.00 12.08 1.000  -
Assessment of LV Dysfunction:
Table 4 shows the relative proportion of patients with normal LV function, mild, moderate, or 
severe LV dysfunction as per the different modalities of measurement using American Society 
of Echocardiography criteria. For purposes of comparison, normal and mild LV dysfunction 
was clubbed as one group and moderate and severe LV dysfunction as another group. This is
clinically relevant as therapeutic decisions would likely be quite different in these 2 categories. 
The Fisher’s exact test was then used to look for a significant difference in the proportion of 
patients in each group; comparing VVI with SPECT and then VVI with 2D echo (Tables 5 & 
Fig.1 Scatter plot showing the relation between VVI EF and 
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6). There were significantly greater proportion of patients categorized as having moderate or 
severe LV dysfunction by VVI (75.5%) when compared to SPECT (34.7%; p= 0.026 vs. VVI) 
as well as 2D echo (32.7%; p=.0.037 vs. VVI).  Figure 2 gives a graphic comparison of the 
proportion of patients with LV dysfunction using SPECT or VVI. As easily seen from the 
graphs, significantly more patients are clustered in the moderate and severe LV dysfunction 
groups by VVI.
Table 4.  LV Dysfunction by 2D echo, SPECT and VVI  (percentages in parentheses)
LV Function 2D echo SPECT VVI
Normal 27 (55.1) 28 (57.1) 2    (4.1)
Mild dysfunction 6   (12.2) 4   (8.2) 10  (20.4)
Moderate 
dysfunction
16 (32.7) 10 (20.4) 22  (44.9)
Severe 
Dysfunction
0   (0) 7  (14.3) 15  (30.6)
Table 5. Statistical Comparison of categorized LV function: SPECT & VVI EF
11 21 32
7.8 24.2 32.0
1 16 17
4.2 12.8 17.0
12 37 49
12.0 37.0 49.0
Count
Expected Count
Count
Expected Count
Count
Expected Count
none or mild
moderate or severe
2 categories SPECT
LV Dysfunction
Total
none or mild
moderate
or severe
2 categories VVI LV
Dysfunction
Total
Chi-Square Tests
4.874 1 .027
3.455 1 .063
5.763 1 .016
.026
4.774 1 .029
Pearson Chi-Square
Continuity Correction
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Table 6. Statistical Comparison of categorized LV function: 2D & VVI EF
11 22 33
8.1 24.9 33.0
1 15 16
3.9 12.1 16.0
12 37 49
12.0 37.0 49.0
Count
Expected Count
Count
Expected Count
Count
Expected Count
none or mild
moderate or severe
2D LV Dysfunction
2 categories
Total
none or mild
moderate
or severe
2 categories VVI LV
Dysfunction
Total
Chi-Square Tests
4.274 1 .039
2.935 1 .087
5.061 1 .024
.037
4.187 1 .041
49
Pearson Chi-Square
Continuity Correction
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
             
                  Figure 2. LV Dysfunction (LVD) by SPECT and VVI
                 
                         
Analysis of Regional Function:
While regional wall motion abnormality (RWMA) was assessed subjectively by 2D echo, 
regional EF was calculated using VVI as described earlier by dividing the trace into 3 
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segments of equal length on each side. These segments labeled 1 to 6 correspond to basal 
inferoseptum, mid inferoseptum, apical septum, apical lateral, mid anterolateral and basal 
anterolateral respectively. The standard for segmental EF is different from that of global EF 
and segmental EF ≥ 35% has been considered normal95.  Table 7 shows the distribution of 
RWMA by 2D echo. About 40% of patients had RWMA in various regions by 2D echo; 
predominantly, this was in the anterior/septum/apical region. By VVI however, 34 of 49 
patients (69.3%) had reduced segmental EF in one or more regions using a cut-off of 35%. 
The frequency of reduced EF (regional dysfunction) in each region is shown in Table 8.
Table 7. RWMA by 2D Echo (percentages in brackets)
RWMA Frequency
None 30 (61.2)
Anterior/septum/ apex 15 (30.6)
Inferior/Posterior/lateral 2 (4.1)
Global hypokinesia 2 (4.1)
Table 8.  Regional Dysfunction by VVI (percentages in brackets)
Region Dysfunction
Region 1- Basal 
inferoseptum
28 (57.1)
Region 2- Mid 
inferospetum
20 (40.8)
Region 3- Apical septum 22 (44.9)
Region 4- Apical lateral 20 (40.8)
Region 5- Mid 
anterolateral
19 (38.8)
Region 6- Basal 
anterolateral
19 (38.8)
Inter-Observer Correlation for measurement of EF by gated SPECT:
The reliability of ejection fraction measured by gated SPECT in this study was tested by 
looking at the inter-observer variation in the calculation of EF from the SPECT images in 12 
randomly selected patients by two independent nuclear physicians. Excellent agreement was 
seen for measured EF by SPECT (Pearsons correlation coefficient 0.992, p=0.01) between 2 
observers, reflecting good reliability of measurement.
Correction Factor for VVI EF:
A regression equation giving the numerical relationship between SPECT EF and VVI EF was 
obtained from the linear scatter plot. The SPECT EF can be calculated from the VVI EF as 
given by the equation: EF (SPECT) = EF (VVI) x 0.9 + 21 or approximately VVI (EF) +20. 
Considering SPECT EF to be the standard in this study, this can be used as a correction 
factor, using which the “correct EF” can be derived from the EF measured by VVI.
DISCUSSION
In this study we have evaluated the new echocardiographic modality of velocity vector 
imaging in the assessment of LV systolic function by ejection fraction.  Though VVI employs a 
complex multi-step algorithm, it is practically easy to use and involves only obtaining a good 
quality image and tracing the endocardial border of the region of interest. The advantage is 
that the border is then automatically tracked through successive cycles and hence cardiac 
motion may be delineated with greater accuracy. Measurement of global and regional EF by 
VVI was found to be simple and feasible enough to be used in routine clinical practice.
There was a positive linear correlation between the EF measured by VVI and the other 
modalities viz SPECT and 2D echo. This means that as the value of EF measured by SPECT 
or 2D echo increases, so does that measured by VVI in a proportionate fashion, and vice 
versa for a fall in the EF. This positive relationship is important as it shows that in a given 
population, relative differences would be reflected well by the new modality even if absolute 
values are not the same. Thus, in the serial follow up of a patient for example, an 
improvement or worsening in the EF reflected by gated SPECT or 2D echo would probably be 
seen on measurement by VVI as well. In other words, the directional trend of EF is the same 
by all three modalities tested.
However as per the results obtained from this study, EF measured by VVI does not appear to 
be accurate in terms of the absolute value. The mean EF as measured by VVI (35 ± 12.08%) 
was significantly less than that measured by either SPECT (54.2 ± 19.51%) or 2D echo (50.3 
± 8.92%). Taken together, the above facts suggest that the current VVI algorithm 
systematically underestimates the ejection fraction as compared to gated SPECT or 2D echo. 
In addition to showing that this difference is significant in absolute terms, we also analyzed 
whether it affects classification into different categories of LV dysfunction as this is more likely 
to directly affect therapy and clinical decision-making. Hence we classified patients by EF into 
normal, mild, moderate or severe LV dysfunction based on standard American Society of 
Echocardiography criteria.  A significantly greater proportion of patients were classified as 
having moderate or severe LV dysfunction by VVI EF as compared to SPECT. Thus, the 
underestimation of EF by VVI is clinically significant.
Analysis of regional function also showed a difference between 2D echo and VVI. While about 
40% of the patients had RWMA on assessment by 2D echo, close to 70% of patients had 
regional dysfunction as evidenced by reduced regional EF in at least one of the six segments 
studied by VVI.  However, an allowance has to be made for the fact that visual estimation by 
2D echo is subjective and may not have been accurate enough to pick out milder degrees of 
hypocontractility which a numerical measure like regional EF would pick up. 
As SPECT was used as the gold standard for comparison in this study, reliability of 
measurement was checked by looking for any variation in measurement between 2 
independent observers in 12 randomly selected patients. The inter observer correlation was 
excellent, showing that measurement error was not likely to be a significant issue in 
calculating EF from gated SPECT.  As mentioned previously, assessment of LV function by 
gated SPECT is a well accepted modality which has been validated against other techniques 
of LV function measurement93. Hence its use in this study as the standard is justified and 
lends credence to the observed results.
Finally, we looked at the numerical relationship between the calculated VVI EF and SPECT 
EF and found by regression equation that the VVI EF was numerically about 20 less than the 
SPECT EF. In other words, the “correct” (SPECT) EF can be known by adding 20 to the VVI 
EF. This can be incorporated as a correction factor in the VVI algorithm to improve its 
accuracy. This will need to be prospectively validated.
It is difficult to speculate as to why there was a significant error in the EF measured by VVI. 
The software is automated and the role of the echocardiographer is limited to only tracing the 
endocardial border, making operator related error unlikely.  To the best of our knowledge, this 
is the first study to attempt to validate EF measured by VVI against an existing standard. 
Studies assessing VVI in the clinical setting are sparse at present. Chen et al studied the use 
of VVI in a small number of post myocardial infarction patients by measuring strain, strain rate 
and segmental EF. They found that these parameters were significantly lower in infarct 
segments than in the corresponding segments of the normal controls. There was good 
correlation between the strain measured by VVI and that measured by tissue Doppler. Inter 
and intraobserver variability in the VVI measurements was 4.6% and 7% respectively. They 
concluded that VVI could be a useful tool in measuring regional myocardial systolic function95. 
Vannan et al., in a case report have described the measurement of strain using VVI in a 
patient undergoing CRT. They showed that although longitudinal and radial velocities of the 
LV were synchronized after CRT, VVI showed a persistent heterogeneity of circumferential 
strain8. Thus, VVI could possibly be a better tool for assessing the outcome of CRT by better 
measuring the circumferential and radial dynamics of the LV, which are components of the 
torsional deformation of the LV described earlier. 
As VVI is a new and still evolving technology, the software and tracking algorithm may need 
to be “fine tuned” as data from more clinical studies become available. There is no doubt that 
VVI is a conceptually sound technology with good future potential and further trials will help 
delineate any possible sources of error which can then be addressed.  
In conclusion, measurement of ejection fraction by VVI is simple and feasible for use in 
clinical practice. This study showed a positive linear correlation between EF measured by 
VVI, gated SPECT and 2D echo. However, VVI significantly underestimated EF in 
comparison to gated SPECT and 2D echo by a magnitude that was clinically relevant in 
classifying patients into categories of LV dysfunction. This could be due to as yet unknown 
technical factors in the tracking algorithm. A correction factor was calculated which can be 
incorporated into the VVI algorithm to improve its accuracy. 
LIMITATIONS
1. The number of patients studied was limited and hence the findings need to be confirmed in 
a larger population.
2. The patients studied are a heterogeneous population in terms of LV function and whether 
any variations exist in the measurement of EF by VVI in different subsets of patients cannot 
be adequately commented upon due to the limited numbers studied.  However, in the current 
study, the relationship between VVI and SPECT EF appeared to be uniform irrespective of 
underlying pathology and extent of LV dysfunction.  
3. This study looked only at ejection fraction; the possible contribution of other techniques like 
strain and strain rate imaging by VVI was not addressed.
SUMMARY OF MAIN FINDINGS
1. VVI is an easy to use technology from which global and regional EF can be calculated.
2. The mean ejection fraction (EF) calculated by VVI was 35 ± 12.08%, as compared to 54.2 
± 19.51% by SPECT (p<0.001 vs. VVI) and 50.3 ± 8.92% with 2D echo (p<0.001 vs. VVI). 
The mean EF measured by VVI was significantly less than that measured by the other 
modalities.
3. There was a positive linear correlation between the VVI EF and SPECT EF (correlation 
coefficient 0.577; p=0.01) as well as 2D EF (correlation coefficient 0.573; p=0.01).
4. Significantly greater proportion of patients were categorized as having moderate or severe 
LV dysfunction by VVI (75.5%) when compared to SPECT (34.7%) or 2D echo (32.7%).
5. There was excellent inter-observer correlation for EF measured by SPECT.
6. A correction factor was derived from the regression equation for VVI EF as follows: EF 
(SPECT) = EF (VVI) x 0.9 + 21 or approximately VVI (EF) +20.
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Proforma
ASSESSMENT OF LV SYSTOLIC FUNCTION BY VELOCITY VECTOR IMAGING
1. Name:                                                   2. Age/sex:                      3. Hosp.No:
4. Risk Factors:         Diabetes:          yes/no
                                  Hypertension:   yes/no
                                  Smoker          :  yes/no
                                  Dyslipidemia:   yes/no
                                  Family history:  yes/no
5. Symptoms:           Angina:              yes/no
                                 Dyspnea:            yes/no
                                 Orthopnea:         yes/no
                                 PND        :          yes/no
                                 Palpitations:       yes/no
                                 Syncope:            yes/no
                                 Fatigue  :            yes/no
           
6. NYHA Class:      I/ II/ III/ IV
7. Previous STEMI:                        yes/no
    If Yes, site:                              Anteroseptal
                                                     Extensive anterior
                                                     Lateral
                                                     Inferior
                                                     Large Inferior (Inferoposterior +/- RVMI)
    Thrombolysed:                          yes/no/not known
8. Previous ACS (other than STEMI):  yes/no
9. ECG:              Q Infarct:             yes/no
                           LBBB    :             yes/no
10. Chest X Ray:    Cardiomegaly: yes/no (CTR-     )
11.  Ejection Fraction:
       By 2D Echo:  Global-
                              RWMA-
       
     By Gated SPECT:  
       
     By VVI       :    Global-
                              Regional-  1.        2.        3.       4.       5.       6.     
12. Sestamibi Results:                         Normal
                                                             Fixed Defect   Region:
                                                             Ischemia          Region:
13. Coronary Angiogram:                     Not Done
                                                               SVD
                                                               DVD
                                                               TVD
                                                               LMD
       LV Angio                                        Normal
                                                               LV Dysfunction     RWMA-
                                                               Hypercontractile LV                       
12. Drugs:             Aspirin:                      yes/no
                              Beta blockers:            yes/no
                              Statin:                         yes/no             Dose: 10/ 20/ 40
                              ACEI/ARB:                yes/no
                               Nitrate:                      yes/no 
GLOSSARY   FOR MASTER CHART 
hospno                                                   - Hospital number
dm                                                         - Diabetes mellitus 
htn                                                         - Hypertension
sm                                                          - Smoking
dyslip                                                     - Dyslpidemia
famhis                                                    - Family History
orthop                                                    - Orthopnea
pnd                                                        - Paroxysmal nocturnal dyspnea
palpit                                                     - Palpitations
nyha                                                      - New York Heart Association functional 
                                                                class
stemi                                                     - ST elevation myocardial infarction
misite                                                    - Site of STEMI
thrombol                                               - Thrombolysis done (NA = not applicable) 
acs                                                        - Acute coronary syndrome (other than 
                                                                STEMI)
qinfar                                                     - Q infarct on ECG
lbbb                                                       - Left Bundle Branch Block on ECG
cmegaly                                                 - Cardiomegaly on chest X-ray
ctr                                                           - Cardiothoracic ratio (%)
twodef                                                     - Ejection fraction by 2D echo
twodlvd                                                     - LV dysfunction by 2D echo     twocat2d 
- LV dysfunction by 2D echo in 2 
                                                                    categories
twodrwma                                                  - RWMA by 2D echo (nil = no RWMA) 
spectef                                                       - Ejection fraction by gated SPECT
intero                                                          - SPECT EF by 2nd independent 
                                                                     observer in 12 cases 
spectlvd                                                     - LV dysfunction by SPECT 
spelvtwo                                                    -  LV dysfunction by SPECT in 2 
                                                                     categories                  
vvief                                                           - Ejection fraction by VVI
vvilvd                                                         - LV dysfunction by VVI
vvilvtwo                                                      - LV dysfunction by VVI in 2 categories
vvireg1 to 6                                                - Segmental EFs in regions 1 to 6 by 
                                                                      VVI
sestamib                                                     - Ischemia by SPECT 
cag                                                              - Coronary angiogram 
                                                                      minor = minor disease
                                                                      SVD = Single vessel disease
                                                                      DVD = Double vessel disease
                                                                      TVD = Triple vessel disease
                                                                      LM = Left main disease
lvangio                                                         - LV angiogram 
rwmalvan                                                     - RWMA by LV angio
                                                                       (NA = not available) 
betabloc                                                       - Beta blocker use
acei                                                             - ACE inhibitor/ ARB use
lvdreg 1-6                                                    -LV dysfunction by reduced segmental 
                                                                     EF in regions 1 to 6 by VVI
